Skip to content

One and a half nostril versus binostril endoscopic transsphenoidal approach for pituitary adenomas

One and a half nostril versus binostril endoscopic transsphenoidal approach for pituitary adenomas

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008222
Enrollment
Unknown
Registered
2016-04-05
Start date
2016-04-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pituitary adenomas

Interventions

Binostril endoscopic transsphenoidal approach for pituitary adenomas:Resecting about a third nasal septum posterior mucosa in surgery
One and a nostril endoscopic transsphenoidal approach for pituitary adenoma: A vertical incision of the left nasal septal mucosa was made with unipolar electrocautery, extending approximately 2 cm at

Sponsors

Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The participators sign the consent form of this study voluntarily; 2) Age greater than or equal to 18 years old, less than or equal to 80 years old, both male and female, and patients with pituitary adenoma; 3) Without central infection and severe systemic infection; 4) No blood coagulation disorders, and no severe liver and kidney impairment; 5) Not pregnancy, nursing mothers.

Exclusion criteria

Exclusion criteria: 1) The anesthesiologist determine patients doesn't fit to the researche; 2) General condition is poor, patients cannot objectively describe the symtom, or have serious infections, respiratory disturbance, or cannot cooperate actively; 3) Intracranial tumor metastasis patients with disturbance of consciousness; 4) Central infection, severe systemic infection; 5) Blood coagulation disorders; Patients with severe liver and kidney impairment: general for twice the normal value; 6)women in gestational or lactational period 7) Directly involved in the research of the sponsor or researchers or their family members; 8) The researchers think that there is any reason not spots.

Design outcomes

Primary

MeasureTime frame
Gross tumor resection;Hormonal remission rate;Visual function improvement;Complications;

Secondary

MeasureTime frame
the length of hospital stay;mean operating time;blood loss volume during the operation;

Countries

China

Contacts

Public ContactChiyuan Ma

Jinling Hospital, School of Medicine, Nanjing University

machiyuan_nju@126.com+86 13401931231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026